AFAR Experts in the News: Sofiya Milman and S. Jay Olshansky in WebMD magazine on genes, longevity, and the TAME Trial
In its September 2018 issue, WedMD magazine highlighted the insights of AFAR experts Sofiya Milman M.D. and S. Jay Olshansky Ph.D.
Dr. Milman is a 2015 Beeson Career Development Awards in Aging Research scholar.
Dr. Olshansky is an AFAR Board Member and 2016 Irving S. Wright Award winner.
The article also explores the Targeting Aging with Metformin (TAME) Trial, which is led by AFAR Deputy Scientific Director Nir Barzilai, M.D. and managed by AFAR.
Read the article--“100: Is It The New 80?”—here.